IP Library › Assignment 057031/0532
Patent Assignment
Reel/Frame 057031/0532

Change of Name

Recorded: 2021-07-29 Pages: 3
Assignor
PHARMACOFORE, INC.
Executed: 2012-01-04
Assignee
SIGNATURE THERAPEUTICS, INC.
1731 EMBARCADERO ROAD, SUITE 220, PALO ALTO, CALIFORNIA, 94303
Covered Property (1)
Compositions Comprising Enzyme-Cleavable Amphetamine Prodrugs and Inhibitors Thereof
Application: 16/656,409 →
Publication: US 2020/0253900
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 29, 2021
From: JENKINS, THOMAS E.; HUSFELD, CRAIG O.; SEROOGY, JULIE D.; WRA Y, JONATHAN W.
To: PHARMACOFORE, INC.
Reel/Frame 057025/0556 →
Security Interest Oct 4, 2021
From: ENSYSCE BIOSCIENCES, INC.
To: 3I, LP
Reel/Frame 057785/0054 →
Security Interest Jul 8, 2022
From: ENSYSCE BIOSCIENCES, INC.; EBI OPCO, INC.; EBI OPERATING, INC.; COVISTAT, INC.
To: 3I, LP
Reel/Frame 060616/0487 →
Security Interest Dec 18, 2023
From: ENSYSCE BIOSCIENCES, INC.; EBI OPCO, INC.; EBI OPERATING, INC.; EBIR, INC.
To: 3I, LP
Reel/Frame 065902/0035 →